OneTrust's AI Governance Committee Framework Sets a Practical Bar for Agentic AI Controls, Including Traceability and Least-Privilege Requirements
What happened
OneTrust published Establishing an AI Governance Committee: An Inside Look at OneTrust's Process on October 20, 2025, detailing the internal steps the company took to stand up a formal AI Governance Committee. The guidance introduces a structured buy-versus-build framework that requires organizations to evaluate third-party AI tools against internally developed alternatives using a consistent risk and capability lens. For agentic AI systems specifically, the framework mandates three controls: restrictions on decision-making authority, full traceability of all actions taken by autonomous systems, and enforcement of least-privilege access to data and system resources. The publication covers global applicability rather than any single jurisdiction, positioning it as a model enterprises can adapt regardless of their primary regulatory environment. By sharing its own internal process, OneTrust has created a named implementation reference that compliance teams can use to pressure-test the maturity of their own AI governance structures.
Why it matters
- ·Agentic AI controls are rapidly becoming a regulatory expectation: frameworks from Singapore's IMDA, the EU AI Act's transparency requirements, and emerging U.S. state laws all point toward mandatory traceability and autonomy restrictions for autonomous systems, and enterprises without documented controls will face audit gaps.
- ·The buy-versus-build framework formalizes a procurement risk decision that most organizations currently handle informally, meaning compliance teams that lack a documented evaluation process are exposed to third-party AI risk they cannot demonstrate they managed.
- ·Publishing a named internal process sets a de facto industry benchmark: regulators and auditors increasingly look to peer practice when assessing reasonableness, so compliance programs that cannot articulate committee structure, decision rights, and agentic controls may be judged against this standard in enforcement or due diligence contexts.
Governance controls affected
What to do now
- ☐Assess whether your organization has a formally chartered AI Governance Committee with documented decision rights, membership criteria, and escalation paths, and close any gap against the OneTrust model.
- ☐Review your current agentic AI deployments against the three-part control set: decision authority restrictions (AGT-001/AGT-004), full action traceability (AGT-006), and least-privilege data access (SEC-004), and document findings for audit purposes.
- ☐Formalize your buy-versus-build evaluation process for third-party AI tools by creating a documented framework that captures risk, capability, and governance criteria before any procurement decision is finalized.
- ☐Cross-reference your AI Governance Committee charter against BRD-002 requirements to confirm it specifies quorum, voting rights, conflict-of-interest handling, and how AI risk appetite decisions are escalated to the board.
- ☐Use the OneTrust framework as a benchmarking input in your next AI governance maturity assessment, identifying which elements your program already satisfies and which represent control gaps requiring remediation.
What to watch next
As agentic AI adoption accelerates into 2026, regulators and standards bodies including the EU AI Office, Singapore's IMDA, and NIST are expected to publish more prescriptive guidance on autonomous system controls, and any gap between voluntary enterprise frameworks and formal regulatory requirements will narrow quickly. Compliance teams should monitor whether industry bodies such as ISO begin incorporating agentic AI traceability requirements into updates to ISO/IEC 42001, and whether enforcement actions under existing frameworks cite inadequate oversight of autonomous AI as an aggravating factor. The buy-versus-build decision point is also likely to attract attention from procurement-focused regulators, particularly in financial services and healthcare, where third-party AI tool intake requirements are tightening.
